Search Count: 73
 |
Organism: Acinetobacter baumannii
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2025-01-15 Classification: OXIDOREDUCTASE Ligands: IMP, VOA |
 |
Organism: Acinetobacter baumannii
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2025-01-15 Classification: OXIDOREDUCTASE Ligands: IMP, VP4 |
 |
Organism: Acinetobacter baumannii
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2025-01-15 Classification: OXIDOREDUCTASE Ligands: IMP, A1AG0 |
 |
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2025-01-15 Classification: OXIDOREDUCTASE Ligands: IMP, VOA |
 |
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2025-01-15 Classification: OXIDOREDUCTASE Ligands: IMP, VP4 |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2025-01-15 Classification: OXIDOREDUCTASE Ligands: IMP, VOA |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2025-01-15 Classification: OXIDOREDUCTASE Ligands: IMP, VP4 |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2025-01-15 Classification: OXIDOREDUCTASE Ligands: IMP, A1AG0 |
 |
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2024-11-27 Classification: OXIDOREDUCTASE Ligands: IMP, A1AG0 |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-11-27 Classification: OXIDOREDUCTASE Ligands: IMP, VOA, SO4 |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-11-27 Classification: OXIDOREDUCTASE Ligands: IMP, A1A3K |
 |
Organism: Acinetobacter baumannii
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2024-09-18 Classification: OXIDOREDUCTASE Ligands: IMP, A1AUF |
 |
Crystal Structure Of Selective Ire1A Inhibitor 29 At The Enzyme Active Site
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.43 Å Release Date: 2024-05-29 Classification: TRANSFERASE/INHIBITOR Ligands: EDO, XOE |
 |
Crystal Structure Of Broadly Neutralizing Antibody Hcab55 In Complex With Hepatitis C Virus Envelope Glycoprotein E2 Ectodomain
Organism: Hepacivirus hominis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2024-03-27 Classification: IMMUNE SYSTEM/VIRAL PROTEIN Ligands: NAG |
 |
Crystal Structure Of Broadly Neutralizing Antibody Hcab64 In Complex With Hepatitis C Virus Envelope Glycoprotein E2 Ectodomain
Organism: Hepacivirus hominis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2024-03-27 Classification: IMMUNE SYSTEM/VIRAL PROTEIN Ligands: NAG |
 |
Crystal Structure Of Broadly Neutralizing Antibody Hcab40 In Complex With Hepatitis C Virus Envelope Glycoprotein E2 Ectodomain
Organism: Hepacivirus hominis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.12 Å Release Date: 2024-03-27 Classification: IMMUNE SYSTEM/VIRAL PROTEIN Ligands: NAG |
 |
Crystal Structure Of Broadly Neutralizing Antibody Hcab17 In Complex With Hepatitis C Virus Envelope Glycoprotein E2 Ectodomain
Organism: Homo sapiens, Hepacivirus hominis
Method: X-RAY DIFFRACTION Resolution:3.31 Å Release Date: 2024-03-27 Classification: IMMUNE SYSTEM/VIRAL PROTEIN Ligands: NAG |
 |
Human Mras Q71R In Complex With Human Shoc2 Lrr Domain M173I And Human Pp1Ca
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-06-22 Classification: HYDROLASE Ligands: GNP, MG, GOL, MN, PO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2022-06-22 Classification: HYDROLASE Ligands: MG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2022-01-26 Classification: ISOMERASE Ligands: PGA |